UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049807
Receipt number R000056729
Scientific Title Health survey for general population during the COVID-19 pandemic
Date of disclosure of the study information 2022/12/16
Last modified on 2022/12/16 14:56:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Health survey for general population during the COVID-19 pandemic

Acronym

Health survey for general population during the COVID-19 pandemic

Scientific Title

Health survey for general population during the COVID-19 pandemic

Scientific Title:Acronym

Health survey for general population during the COVID-19 pandemic

Region

Japan


Condition

Condition

COVID-19

Classification by specialty

Medicine in general Pneumology Infectious disease
Emergency medicine Adult Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the presence of long-term symptoms after COVID-19, physical and mental health, and socioeconomic status of patients with COVID-19 and age-, sex-, and area-matched non-infected residents

Basic objectives2

Others

Basic objectives -Others

Presence of long-term symptoms after COVID-19, physical and mental health, and socioeconomic status

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Presence of long-term symptoms after COVID-19 and new onset diseases

Key secondary outcomes

Physical and mental health, socioeconomic status, lifestyles, and status of taking medical care


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit

79 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Persons who live in Yao city and were diagnosed with COVID-19 between March 2021 and April 2022 (COVID-19 group) and age-, sex-, area (elementary school area)- matched non-infected residents* (Control group)
2) Those aged between 5 years and 79 years**
3) Those who have consented to participate in this study
*We excluded those who were diagnosed with COVID-19 between January 2020 and the date of participant selection
**age at the time of participant selection

Key exclusion criteria

Persons deemed unfit by the principal investigator
(e.g., those who have moved out of the city or died at the time of participant selection)

Target sample size

8000


Research contact person

Name of lead principal investigator

1st name Hiroyasu
Middle name
Last name Iso

Organization

National Center for Global Health and Medicine

Division name

Institute for Global health Policy Research, Bureau of International Health Cooperation

Zip code

162-8655

Address

1-21-1, Toyama Shinjuku-ku, Tokyo, Japan

TEL

03-3202-7181

Email

hiso@it.ncgm.go.jp


Public contact

Name of contact person

1st name Mariko
Middle name
Last name Hosozawa

Organization

National Center for Global Health and Medicine

Division name

Institute for Global health Policy Research, Bureau of International Health Cooperation

Zip code

162-8655

Address

1-21-1, Toyama Shinjuku-ku, Tokyo, Japan

TEL

03-3202-7181

Homepage URL


Email

mhosozawa@it.ncgm.go.jp


Sponsor or person

Institute

National Center for Global Health and Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, National Center for Global Health and Medicine

Address

1-21-1, Toyama Shinjuku-ku, Tokyo, Japan

Tel

03-3202-7181

Email

rinrijm@hosp.ncgm.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

11931

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 08 Month 09 Day

Date of IRB

2022 Year 06 Month 23 Day

Anticipated trial start date

2022 Year 11 Month 01 Day

Last follow-up date

2022 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a cross-sectional study of patients who live in Yao city, Osaka, and were diagnosed with COVID-19 between March 2021 and April 2022, and age-, sex-, and area-matched non-infected residents. A self-administered questionnaire will be used to examine long-term symptoms associated with COVID-19, new onset diseases, physical and mental health, and socioeconomic status.


Management information

Registered date

2022 Year 12 Month 16 Day

Last modified on

2022 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056729


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name